產(chǎn)品編號 | bsm-62321R |
英文名稱 | TFPI Recombinant Rabbit mAb |
中文名稱 | 組織因子途徑抑制劑重組兔單抗 |
別 名 | EPI; LACI; TFI; TFPI1. |
抗體來源 | Rabbit |
克隆類型 | Recombinant |
克 隆 號 | |
交叉反應(yīng) | Human |
產(chǎn)品應(yīng)用 | WB=1:1000-1:2000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理論分子量 | 35 kDa |
檢測分子量 | 35-45 |
性 狀 | Liquid |
免 疫 原 | A synthesized peptide derived from human TFPI: 250-304/304 |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
緩 沖 液 | 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. |
保存條件 | Store at 4℃ for short term. Store at -20℃ for long term. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產(chǎn)品介紹 |
Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma. SWISS: P10646 Gene ID: 7035 組織因子途徑抑制因子(tissue factor pathway in hibitor, TFPI)是組織因子凝血途徑的主要抑制因子, 組織因子途徑抑制因子在諸如動脈粥樣硬化,血管再狹窄,彌漫性血管內(nèi)凝血DIC等方面,有一定的研究價值 |
產(chǎn)品圖片 | |